Related Experiment Videos
Anti-inflammatory therapy during pregnancy and lactation
Summary
This study reviews anti-inflammatory drugs during pregnancy. While generally considered safe, acetylsalicylic acid (ASA) and other NSAIDs may cause prolonged labor and increased blood loss, especially in the first trimester.
Area of Science:
- Pharmacology
- Obstetrics
- Teratology
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and other immunomodulatory agents are frequently used for various medical conditions.
- Understanding the safety profile of these medications during pregnancy is crucial for both maternal and fetal well-being.
- Previous research has indicated varying safety profiles for different drug classes during gestation.
Purpose of the Study:
- To evaluate the safety and potential teratogenic effects of commonly used anti-inflammatory drugs during human pregnancy.
- To provide guidance on the use of NSAIDs, including acetylsalicylic acid (ASA), corticosteroids, and immunosuppressive agents during pregnancy.
- To highlight potential adverse effects associated with specific anti-inflammatory medications in pregnant individuals.
Main Methods:
- Review of existing literature and clinical data on the use of anti-inflammatory drugs in pregnant populations.
- Analysis of reported congenital defects and adverse pregnancy outcomes associated with specific drug classes.
- Comparison of the safety profiles of different NSAIDs, corticosteroids, and immunosuppressants.
Main Results:
- Acetylsalicylic acid (ASA) and other NSAIDs, along with corticosteroids, are not generally considered teratogenic in humans.
- Chloroquine has been associated with congenital defects, while gold and D-penicillamine appear safer.
- Azathioprine is suggested as a potentially safe immunosuppressive agent during pregnancy.
- ASA is often the preferred NSAID due to extensive clinical experience, but can prolong labor and increase blood loss.
Conclusions:
- While most anti-inflammatory drugs carry relatively low risks, unnecessary exposure, particularly in the first trimester, should be avoided.
- Medication use should be minimized throughout pregnancy whenever possible.
- Further research may be needed for less-studied NSAIDs to fully elucidate their safety profiles in pregnancy.